March 3, 2008, Claraview, Inc. was acquired by Teradata Corporation (NYSE: TDC). Claraview is a leading strategy and technology consultancy that helps companies and government agencies use business intelligence to achieve competitive advantage and operational excellence. Teradata Corporation is the global leader in data warehousing and analytic technologies. Outcome Capital acted as financial advisor to Claraview on this transaction.
Sid Banerjee, Founder and CEO of Claraview, commented, “When we started Claraview seven years ago, we set out to build a world class professional services organization with people singularly dedicated to planning, designing, and implementing complex business intelligence and data warehousing solutions for our corporate and government clients. Like Claraview, Teradata is focused on data warehousing, and Claraview’s business intelligence expertise greatly complements Teradata’s solutions. The combination of Teradata and Claraview is a terrific outcome for our people who are dedicated to continuing our leadership in the world of business intelligence and data analytics as part of Teradata.”
Terms of the transaction are undisclosed.
About Claraview, Inc.
Claraview is an industry leader in implementing business intelligence solutions that enable organizations to more efficiently analyze data and make better business decisions. Claraview is 100% focused on business intelligence and data warehousing and is staffed with experts in all facets of BI/DW system deployment.
About Teradata Corporation
Teradata Corporation is the global leader in data warehousing and analytic technologies. Teradata offers a robust and innovative portfolio of horizontal and industry analytical applications for data warehousing, customer management, finance and performance management, and demand and supply chain analysis and management. Teradata delivers integrated, enterprise-scale analytical solutions based on the most powerful, scalable and reliable technology platform in the industry.
BOSTON–(BUSINESS WIRE)–Outcome Capital, a highly specialized life sciences and healthcare advisory and investment banking firm, today announced that ELIOS Vision, Inc. completed a growth financing round to support its European commercialization. Outcome Capital served as the exclusive strategic and financial advisor to the company. ELIOS’ implant-free, minimally invasive Excimer Laser Trabeculostomy glaucoma procedure is approved […]Read More
Outcome Capital Life Science Market Pulse July 2022 Click to view our LifeSciences Pulse NewsletterDownload